A Model to Predict Risk of Hyperkalemia in Patients with Chronic Kidney Disease Using a Large Administrative Claims Database
Ajay Sharma,1 Paula J Alvarez,2 Steven D Woods,2 Dingwei Dai1 1Healthagen, An Affiliate of Aetna Inc., A Part of the CVS Health Family of Companies, New York, NY, USA; 2Managed Care Health Outcomes, Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA, USACorrespondence: Dingwei DaiHealthag...
Main Authors: | Sharma A, Alvarez PJ, Woods SD, Dai D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/a-model-to-predict-risk-of-hyperkalemia-in-patients-with-chronic-kidne-peer-reviewed-article-CEOR |
Similar Items
-
Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management
by: Sarnowski A, et al.
Published: (2022-08-01) -
Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
by: Enrique Morales, et al.
Published: (2021-06-01) -
Hyperkalemia in CKD: an overview of available therapeutic strategies
by: Davide Costa, et al.
Published: (2023-07-01) -
Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study)
by: Bjune T, et al.
Published: (2023-03-01) -
The Impact of Potassium Binders on Mortality in Patients with Hyperkalemia: A Single-Center Study
by: Hajime Nagasu, et al.
Published: (2023-06-01)